Utilization of an ex vivo human placental perfusion model to predict potential fetal exposure to carboplatin during pregnancy

American Journal of Obstetrics and Gynecology

Volumn 210, Issue 3, 2014, Pages 275.e1-275.e9

  Smith, Judith A ^a,b   Gaikwad, Anjali ^b   Mosley, Scott ^b   Coffer II, Larry ^b   Cegelski, Jeffrey ^b   Alcorn, Joseph L ^a   Ramin, Susan M ^c   Refuerzo, Jerrie S ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

carboplatin; fetal; placenta; pregnancy; toxicity

Indexed keywords

APOPTOSIS INDUCING FACTOR; CARBOPLATIN; PHENAZONE; PROTEIN BAX; PROTEIN P53;

APOPTOSIS; AREA UNDER THE CURVE; BLOOD LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG CLEARANCE; EMBRYO; EX VIVO STUDY; EXPLANT; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; KIDNEY CELL; PLACENTA PERFUSION; PLACENTAL TRANSFER; PREDICTION; PREGNANT WOMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; TROPHOBLAST;

CARBOPLATIN; FETAL; PLACENTA; PREGNANCY; TOXICITY;

ADULT; ANTINEOPLASTIC AGENTS; CARBOPLATIN; FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; PLACENTA; PREGNANCY;

EID: 84894587308     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2013.12.013     Document Type: Conference Paper

References (32)

1. M.K. Oehler, G.V. Wain, and A. Brand Gynecologic malignancies in pregnancy: a review Aust N Z J Obstet Gynaecol 43 2003 414 420
2. Ries L, Eisner M, Kosary C, et al. [Internet]. SEER cancer statistics review, 1975-2000. Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975-2000, 2003. Accessed Feb. 3, 2003.
3. P.A. Wingo, T. Tong, and S. Bolden Cancer statistics, 1995 CA Cancer J Clin 45 1995 8 30
4. L.H. Smith, J.L. Dalrymple, G.S. Leiserowitz, B. Danielsen, and W.M. Gilbert Obstetrical deliveries associated with maternal malignancy in California 1992 through 1997 Am J Obstet Gynecol 184 2001 1504 1512
5. J.A. Martin, B.L. Smith, T.J. Mathews, and S.J. Ventura Births and deaths: preliminary data for 1998 Natl Vital Stat Rep 47 1999 1
6. M.L. Anderson, G. Mari, and P.E. Schwartz Gynecologic malignancies in pregnancy E.R. Barnea, Cancer and pregnancy 2001 Springer-Verlag London 33 49
7. B. Moran, H. Yano, N.A. Zahir, and M. Farquharson Conflicting priorities in surgical intervention for cancer in pregnancy Lancet Oncol 8 2007 536 544
8. T.A. Dinh, and D.P. Warshal The epidemiology of cancer in pregnancy E.R. Barnea, Cancer and pregnancy 2001 Springer-Verlag London 1 5
9. G. Pentheroudakis, and N. Pavlidis Cancer and pregnancy: poena magna, not anymore Eur J Cancer 42 2005 126 140
10. W.F. Rayburn Cancer complicating pregnancy foreword Obstet Gynecol Clin North Am 32 2005 xiii xiv
11. E. Cardonick, and A. Iacobucci Use of chemotherapy during human pregnancy Lancet Oncol 5 2004 283 291
12. M.K. Sanyal Metabolism of chemotherapeutic drugs by maternal and conceptus tissues E.R. Barnea, Cancer and pregnancy 2001 Springer-Verlag London 149 173
13. S. Hundertmark, H. Bühler, and M. Fromm et al. Ontogeny of 11β-hydroxysteriod dehydrogenase: activity in the placenta, kidney, colon of fetal rats and rabbits Horm Metab Res 33 2001 78 83
14. V. Dantzer, R. Leiser, P. Kaufmann, and M. Luckhardt Comparative morphological aspects of placental vascularization Placenta 3 1988 235 260
15. R.E. Bawdon, S. Sobhi, and J. Dax The transfer of anti-human immunodeficiency virus nucleoside compounds by the term human placenta Am J Obstet Gynecol 167 1992 1570 1574
16. S. Roberts, R. Bawdon, S. Sobhi, J. Dax, L. Gilstrap, and D. Wimberly The maternal-fetal transfer of bisheteropiperazine (U-87201-E) in the ex vivo human placenta Am J Obstet Gynecol 172 1995 88 91
17. H.J. Holmes, B.M. Casey, and R.E. Bawdon Placental transfer of rosiglitazone in the ex vivo human perfusion model Am J Obstet Gynecol 195 2006 1715 1719
18. S.L. Bloom, K.M. Dias, R.E. Bawdon, and L.C. Gilstrap The maternal-fetal transfer of lamivudine in the ex-vivo human placenta Am J Obstet Gynecol 176 1997 29
19. L.C. Gilstrap, R.E. Bawdon, S.W. Roberts, and S. Sobhi The transfer of the nucleoside analog ganciclovir across the perfused human placenta Am J Obstet Gynecol 170 1994 967
20. A.K. Sood, M.S. Shahin, and J.I. Sorosky Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy Gynecol Oncol 83 2001 599 600
21. L.E. Méndez, A. Mueller, E. Salom, and V.H. González- Quintero Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer Obstet Gynecol 102 2003 1200 1202
22. J.C. Challier Criteria for evaluating perfusion experiments and presentation of results Contrib Gynecol Obstet 13 1985 32 39
23. J.M. Snyder, J.M. Jojnston, and C.R. Mendelson Differentiation of type II cells of human fetal lung in vitro Cell Tissue Res 220 1981 17 25
24. E. Al-Saleh, M. Nandakumaran, I. Al-Rashdan, J. Al-Harmi, and M. Al-Shammari Maternal-fetal transport kinetics of carboplatin in the perfused human placental lobule: in vitro study J Matern Fetal Neonatal Med 20 2007 695 701
25. H. Fox The development and structure of the placenta J.L. Bennington, Pathology of the placenta 1978 W. B. Saunders Co London 38 49
26. B.V.R. Sastry Techniques to study human placental transport Adv Drug Deliver Rev 38 1999 17 39
27. E.M. Van der Aa, J.H.J.C. Peereboom-Stegeman, J. Noordhoek, F.W.J. Gribnau, and F.G.M. Russel Mechanisms of drug transfer across the human placenta Pharm World Sci 20 1998 139 148
28. C. Prouillac, and S. Lecoeur The role of the placenta in fetal exposure to xenobiotics: importance of membrane transporters and human models for transfer studies Drug Metab Dispos 38 2010 1623 1635
29. R. Safaei, and S.B. Howell Copper transporters regulate the cellular pharmacology and sensitivity to PT drugs Crit Rev Oncol Hematol 53 2005 13 23
30. J.A. Sprowl, R.A. Ness, and A. Sparreboom Polymorphic transporters and platinum pharmacokinetics Drug Metab Pharmacokinet 28 2013 19 27
31. E. Ulukaya, F. Ozdikicioglu, A.Y. Oral, and M. Demirci The MTT assay yields a relatively lower result of growth inhibition than the ATP assay depending on the chemotherapeutic drugs tested Toxicol In Vitro 22 2008 232 239
32. J.A. Smith, H. Ngo, M.C. Martin, and J.K. Wolf An evaluation of cytotoxicity of the taxane and platinum agents combination treatment in a panel of human ovarian carcinoma cell lines Gynecol Oncol 98 2005 141 145